ticagrelor &#160; ingelesa (Q420542)

Ticagrelor (ingelesa)

19 urria 2016

formula kimikoa

C₂₃H₂₈F₂N₆O₄S

Erreferentzia bat

Ticagrelor (ingelesa)

19 azaroa 2016

SMILES

CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO

Erreferentzia bat

Ticagrelor (ingelesa)

19 azaroa 2016

isomeric SMILES ^ingelesa

CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO

Erreferentzia bat

Ticagrelor (ingelesa)

19 azaroa 2016

defined daily dose ^ingelesa

0,18 gramo

route of administration ^ingelesa

aho emate

Erreferentzia bat

https://www.whocc.no/atc_ddd_index/?code=B01AC24

active ingredient in ^ingelesa

Brilique ^ingelesa

Erreferentzia bat

European Medicines Agency product number ^ingelesa

EMEA/H/C/001241

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001241/human_med_001398.jsp

22 martxoa 2017

Possia ^ingelesa

Erreferentzia bat

European Medicines Agency product number ^ingelesa

EMEA/H/C/002303

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002303/human_med_001399.jsp

22 martxoa 2017

Brilinta ^ingelesa

Erreferentzia bat

RxNorm ^ingelesa

RxNorm ID ^ingelesa

1116636

14 otsaila 2018

World Health Organisation international non-proprietary name ^ingelesa

ticagrelor (ingelesa)

Erreferentzia bat

ChEBI-ren identifikatzailea

ChEBI ^ingelesa

68558

ticagrelor (ingelesa)

19 urria 2016

medical condition treated ^ingelesa

acute myocardial infarction ^ingelesa

Erreferentzia bat

2 urria 2018

unstable angina ^ingelesa

Erreferentzia bat

2 urria 2018

acute coronary syndrome ^ingelesa

Erreferentzia bat

2 urria 2018

kardiopatia

Erreferentzia bat

2 urria 2018

significant drug interaction ^ingelesa

nabumetone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Naproxeno

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diklofenako

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Piroxicam

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

meloxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-fenoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(+-)-flurbiprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ibuprofeno

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

indomethacin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-ketoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-etodolac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sulindac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

parecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

aceclofenac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenoxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

vortioxetine ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ibrutinib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Paroxetina

side effect ^ingelesa

Erreferentzia bat

seguruenik

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Sertralina

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fluvoxamine ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Fluoxetina

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-citalopram ^ingelesa

side effect ^ingelesa

Erreferentzia bat

seguruenik

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Azido azetilsaliziliko

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

anagrelide ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

enoxaparin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dalteparin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

urokinase ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tinzaparin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Warfarina

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fondaparinux ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

alteplase ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Heparina

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Azenokumarol

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

phenindione ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenecteplase ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Streptokinase ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

rivaroxaban ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

apixaban ^ingelesa

side effect ^ingelesa

Erreferentzia bat

fisikoki honekin elkarrekintza du

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Purinergic receptor P2Y12 ^ingelesa

subjektuak duen rola

Antagonista (biokimika)

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

Guide to Pharmacology Ligand ID ^ingelesa

1765

17 abuztua 2016

legal status (medicine) ^ingelesa

boxed warning ^ingelesa

Erreferentzia bat

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (ingelesa)

pregnancy category ^ingelesa

US pregnancy category C ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

subjektuak duen rola

xenobiotic-transporting ATPase inhibitor ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

N0000182973

5 martxoa 2018

purinergic P2Y receptor antagonists ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C503700

InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1

15 martxoa 2018

Commons-eko kategoria

Ticagrelor

0 erreferentzia

Identifikatzaileak

InChI

Erreferentzia bat

Ticagrelor (ingelesa)

19 azaroa 2016

2 erreferentzia

Ticagrelor (ingelesa)

19 azaroa 2016

ChEBI release 2020-09-01 ^ingelesa

CAS zenbakia

274693-27-5

2 erreferentzia

Global Substance Registration System ^ingelesa

UNII

GLH0314RVC

ticagrelor (ingelesa)

19 azaroa 2016

CAS Common Chemistry ^ingelesa

10 apirila 2021

https://commonchemistry.cas.org/detail?cas_rn=274693-27-5

ChemSpider-ren identifikatzailea

8047109

Erreferentzia bat

ChemSpider-ren identifikatzailea

ChemSpider ^ingelesa

8047109

Ticagrelor (ingelesa)

19 azaroa 2016

2 erreferentzia

Ticagrelor (ingelesa)

19 azaroa 2016

Reaxys registry number ^ingelesa

15468079

Erreferentzia bat

ChEBI-ren identifikatzailea

ChEBI ^ingelesa

68558

ticagrelor (ingelesa)

ChEBI-ren identifikatzailea

19 urria 2016

68558

mapping relation type ^ingelesa

exact match ^ingelesa

2 erreferentzia

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL398435

TICAGRELOR (ingelesa)

19 azaroa 2016

InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1

International Chemical Identifier ^ingelesa

InChI

ChEMBL-en identifikatzailea

CHEMBL398435

Erreferentzia bat

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL398435

TICAGRELOR (ingelesa)

19 azaroa 2016

SureChEMBL ID ^ingelesa

SCHEMBL1979652

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

UniChem compound ID ^ingelesa

18217

Erreferentzia bat

UniChem ^ingelesa

HSDB ID ^ingelesa

8306

Erreferentzia bat

Hazardous Substances Data Bank ^ingelesa

HSDB ID ^ingelesa

8306

argitaratze-data

28 urria 2019

Ticagrelor (ingelesa)

10 maiatza 2021

DSSTox substance ID ^ingelesa

DTXSID901009337

Erreferentzia bat

DSSTOX compound identifier ^ingelesa

DTXCID501436166

0 erreferentzia

EC zenbakia

619-540-9

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.114.746

27 abendua 2018

(1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (ingelesa)

quotation ^ingelesa

CAS no.: 274693-27-5 (ingelesa)

ECHA Substance Infocard ID ^ingelesa

100.114.746

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.114.746

27 abendua 2018

(1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (ingelesa)

quotation ^ingelesa

CAS no.: 274693-27-5 (ingelesa)

ATC kodea

B01AC24

Erreferentzia bat

DrugBank ^ingelesa

DrugBank ID ^ingelesa

08816